The weekly litigation news digest is live. Subscribe now

IP Verse

Arcutis competitive analysis

Loading summary...

Latest patents of Arcutis opposed by its competitors

Explore Arcutis's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3634380
Jan 10, 2024Inhibition Of Crystal Growth Of Roflumilast1
EP3684334
Dec 6, 2023Pharmaceutical Compositions Of Roflumilast In Aqueous Blends Of Water-Miscible, Pharmaceutically Acceptable Solvents1

Latest PTAB cases involving Arcutis

Discover the latest PTAB cases involving Arcutis, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Arcutis with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ARCUTIS BIOTHERAPEUTICS - 2 - -
TEVA PHARMACEUTICALS20916 - 12